Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.245 USD | -0.18% | -5.07% | -2.49% |
13/06 | Voyager Therapeutics Names Nathan Jorgensen as Finance Chief | MT |
13/06 | Voyager Therapeutics, Inc. Appoints Nathan Jorgensen as Chief Financial Officer, Effective July 8, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.49% | 449M | |
+34.90% | 52.85B | |
-7.29% | 38.87B | |
+35.43% | 38.24B | |
-10.77% | 26.79B | |
+11.93% | 26.16B | |
-18.35% | 19.9B | |
+36.50% | 13.18B | |
+29.36% | 12.24B | |
-2.95% | 11.79B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Chardan Adjusts Price Target on Voyager Therapeutics to $6.50 From $15, Maintains Neutral Rating